Achilles Therapeutics plc

NASDAQ:ACHL

1.19 (USD) • At close January 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -69.935-71.176-61.099-33.199-13.99-0.007
Depreciation & Amortization 4.7133.693.2880.7720.3020
Deferred Income Tax 000.15900.0140
Stock Based Compensation 6.3577.0226.3172.9920.7190
Change In Working Capital 10.409-5.956-7.9313.004-1.178-0.001
Accounts Receivables 000000
Inventory 000000
Accounts Payables 01.907-2.5725.2580.5480
Other Working Capital 10.409-7.863-5.359-2.254-1.726-0.001
Other Non Cash Items 0.0076.885-0.0181.179-0.009-0
Operating Cash Flow -48.449-59.535-59.284-25.252-14.142-0.008
Investing Activities:
Investments In Property Plant And Equipment -1.1-7.512-7.634-11.847-0.942-0
Acquisitions Net 000000
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 0-7.512-7.634000
Investing Cash Flow -1.1-7.512-7.634-11.847-0.942-0
Financing Activities:
Debt Repayment 000000
Common Stock Issued 0.0090.001160.736114.58894.010
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 00160.755113.70493.2340.014
Financing Cash Flow 0.0090.0010.161113.70493.6220.014
Other Information:
Effect Of Forex Changes On Cash 7.741-25.935-5.3343.658.3730
Net Change In Cash -41.799-92.98188.50380.25586.9110.006
Cash At End Of Period 131.572173.371266.352177.84997.5940.011